Associated tags: Medical device, Mayo Clinic, Hospital, Biochemistry, Urine, Health, PH, Medical imaging, Health maintenance organization, Mineral, VC, Therapy, EHV, Biomarker, SCI, Assuta Medical Center, Ageing, HR, Vitamin, Diagnosis
Olive,
Dehydration,
Color,
Mayo Clinic,
Physics,
UTI,
HIPPA,
Urination,
Urinary tract infection,
Technology,
Urine,
Man,
CEO,
Medtech,
Health,
PH,
CE marking,
Defecation,
Protein,
FDA,
Kidney,
Pressure,
Quality of life,
Patient,
Risk,
GDPR,
Israel Innovation Authority,
AI,
Hospital,
Medical device,
Medical imaging,
Chemistry,
Nitrite,
Biochemistry Olive KG performs high quality analysis of important parameters in the patients' urine in each urination without user intervention.
Key Points:
- Olive KG performs high quality analysis of important parameters in the patients' urine in each urination without user intervention.
- The user does nothing more than urinate in the toilet the same way they have been their whole lives.
- Among other parameters, the device measures red blood cells, proteins, Nitrites, pH levels, alongside features such as volume, pressure, color, and frequency of urination.
- "The milestone of receiving the CE Marking provides validation for our vision and technology and paves the way for us to enter the European market," said Guy Goldman, CEO of Olive Diagnostics.
Biochemistry,
Partnership,
PH,
Mineral,
VC,
Therapy,
Health,
EHV,
Biomarker,
Hospital,
Health maintenance organization,
Urine,
Marketing,
CEO,
Assuta Medical Center,
Ageing,
SCI,
Technology,
HR,
Vitamin,
Mayo Clinic,
Diagnosis,
Ecosystem,
Assuta Ashdod Medical Center,
Maccabi Healthcare Services,
Medical imaging,
Medical device "Taking our next step in building the #UriNation we will see our devices in aged care homes around the world!"
Key Points:
- "Taking our next step in building the #UriNation we will see our devices in aged care homes around the world!"
- "One might say 'ur-ine luck' with the volume of data that is seamlessly collected before a user can even flush!
- The solution will bolster early detection and accurate early intervention to help combat rising healthcare costs and improve user's quality of life.
- Venturing is one of the founding investors in Olive Diagnostics who partners with both early and late-stage hi-tech startups and companies.
Biochemistry,
Partnership,
PH,
Mineral,
VC,
Therapy,
Health,
EHV,
Biomarker,
Hospital,
Health maintenance organization,
Urine,
Marketing,
CEO,
Assuta Medical Center,
Ageing,
SCI,
Technology,
Venturing,
HR,
Vitamin,
Mayo Clinic,
Diagnosis,
Ecosystem,
Assuta Ashdod Medical Center,
Maccabi Healthcare Services,
Medical imaging,
Medical device JERUSALEM, Oct. 4, 2021 /PRNewswire/ -- Olive Diagnostics, developer of the world's first optical sensor for passive and seamless uranalysis technology at home, begins a round of funding led by the Maccabi Foundation. The strong vote of confidence from the healthcare sector sends a clear signal of the need for the company's non-invasive urinalysis device and data.
Key Points:
- "Taking our next step in building the #UriNation we will see our devices in aged care homes around the world!"
- "One might say 'ur-ine luck' with the volume of data that is seamlessly collected before a user can even flush!
- The solution will bolster early detection and accurate early intervention to help combat rising healthcare costs and improve user's quality of life.
- Venturing is one of the founding investors in Olive Diagnostics who partners with both early and late-stage hi-tech startups and companies.
Retrieved on:
Tuesday, September 1, 2020
MENLO PARK, Calif., Sept. 1, 2020 /PRNewswire/ -- Olive Diagnostics, a digital healthcare and diagnostic solutions provider, transforms in-home urinalysis with the world's only functional, hands-free, non-invasive prototype: K2.
Key Points:
- MENLO PARK, Calif., Sept. 1, 2020 /PRNewswire/ -- Olive Diagnostics, a digital healthcare and diagnostic solutions provider, transforms in-home urinalysis with the world's only functional, hands-free, non-invasive prototype: K2.
- K2 mounts to any toilet, detecting urine's molecular composition, generating secure, personalized diagnostic data, directly linked via mobile app.
- K2 transforms an everyday activity into a personalized, convenient, tech-savvy healthcare tool; a golden opportunity for investors during upcoming Series A funding.
- Olive Diagnostics' initial funding comes from Cleveland Clinic, Amgen, Israeli Innovation Authority, eHealth Ventures and private European-American investors.
Retrieved on:
Tuesday, September 1, 2020
MENLO PARK, California, Sept. 1, 2020 /PRNewswire/ -- Olive Diagnostics, a digital healthcare and diagnostic solutions provider, transforms in-home urinalysis with the world's only functional, hands-free, non-invasive prototype: K2.
Key Points:
- MENLO PARK, California, Sept. 1, 2020 /PRNewswire/ -- Olive Diagnostics, a digital healthcare and diagnostic solutions provider, transforms in-home urinalysis with the world's only functional, hands-free, non-invasive prototype: K2.
- K2 mounts to any toilet, detecting urine's molecular composition, generating secure, personalized diagnostic data, directly linked via mobile app.
- K2 transforms an everyday activity into a personalized, convenient, tech-savvy healthcare tool; a golden opportunity for investors during upcoming Series A funding.
- Olive Diagnostics' initial funding comes from Cleveland Clinic, Amgen, Israeli Innovation Authority, eHealth Ventures and private European-American investors.
